In controlled clinical studies, conjunctival injection, headaches, and rhinitis were reported at an incidence of 10 to 25%. The following ocular and non-ocular adverse reactions were reported at an incidence of less than 5%: Zaditen 0.25 mg/ml, eye drops, solution Ketotifen